ACP DiabetesMonthly
Welcome to this month's issue of ACP DiabetesMonthly, an update for internists published by the American College of Physicians.
In the News for the month of May 2013
Highlights
Half of diabetics do not meet recommended care goals
Almost half of U.S. adults with diabetes did not meet recommended goals for diabetes care, despite improvements in controlling risk factors and adhering to preventive practices from 1999 to 2010, a study concluded. More...
New calculator predicts two-year mortality risk in type 2 diabetes
Researchers have developed a new Web-based calculator that predicts short-term mortality risk in patients with type 2 diabetes. More...
Aspirin therapy not associated with cardiovascular benefit in type 2 diabetes
Aspirin showed no cardiovascular benefit and may have been associated with worse outcomes in a recent study of patients with type 2 diabetes. More...
Test yourself
MKSAP Quiz: hypoglycemia unawareness
This month's quiz asks readers to evaluate a 33-year-old woman with multiple recent episodes of severe hypoglycemia. More...
From ACP InternistWeekly
Mortality, hospitalization may be similar with sitagliptin versus other oral antidiabetics
Sitagliptin was associated with similar rates of hospital admission and mortality as other glucose-lowering drugs, according to a recent study of patients with type 2 diabetes. More...
Consensus statement offers strategies for preventing hypoglycemia
Consequences of hypoglycemia and strategies to prevent this condition in patients with diabetes were discussed in a recent consensus statement from the American Diabetes Association (ADA) and The Endocrine Society. More...
Metformin appears safe for heart failure patients, analysis finds
Metformin appears to be a safe option for glycemic control in heart failure patients, according to a recent meta-analysis. More...
From ACP Internist
Patients with diabetes facing vision loss at ever-earlier ages
The growing problem of diabetic retinopathy in young people and the need for response by primary care clinicians are discussed in the April ACP Internist. More...
From ACP Journal Club
Review: Dipeptidyl peptidase-4 inhibitors do not increase overall adverse events in type 2 diabetes
A meta-analysis included 67 randomized controlled trials comparing dipeptidyl peptidase-4 (DPP-4) inhibitors to placebo or other oral antidiabetic agents. More...
Metformin reduced CV events compared with glipizide in patients with type 2 diabetes and CAD
A multicenter randomized controlled trial of Chinese patients with type 2 diabetes and coronary artery disease found that metformin reduced cardiovascular events more than glipizide at 5 years. More...
Tool of the month
What do I need to tell my patients about hypoglycemia?
Some key messages should be given to patients about avoiding and treating hypoglycemia. More...
FDA update
Single and combo diabetes drugs approved
Alogliptin (Nesina) and two new combination drugs (alogliptin and metformin hydrochloride [Kazano] and alogliptin and pioglitazone [Oseni]) were approved by the FDA to improve blood glucose control in adults with type 2 diabetes, along with diet and exercise. More...
Incretin mimetics' effects on pancreas under investigation
The FDA is investigating reports of possible increased risk of pancreatitis and precancerous findings of the pancreas from incretin mimetic drugs for type 2 diabetes. More...
Keeping tabs
Spotlight on bariatric surgery
Treatment of type 2 diabetes with bariatric surgery was discussed by several recent publications, including updated guidelines from a group of medical specialty organizations. More...
Physician editor: David V. O'Dell, MD, FACP
Has Your Contact Information Changed?
To change your e-mail address or other contact information in our records, go here or call 800-523-1546, ext. 2600 (M-F, 9 a.m. - 5 p.m. ET).
About Your Subscription
You are receiving this newsletter as a benefit of your ACP membership. To unsubscribe, simply send a blank e-mail to leave-105814-17003158N@acpnews.org.
ACP DiabetesMonthly is a monthly newsletter produced by the staff of ACP Internist. Please forward any comments or suggestions to acpinternist@acponline.org.
ACP respects your privacy and will not sell, lease or share your e-mail address with any other organization. The College will only use e-mail for the purpose of conducting College business and for communicating with College members.
Copyright © by American College of Physicians.
Test yourself
A 52-year-old man is evaluated in the emergency department for a 5-day history of right leg pain and swelling. He has never had a previous episode of venous thromboembolism.
Ceramic Bistro-Style ACP Mug
Enjoy your morning brew and show your ACP spirit with our 15-ounce dishwasher- and microwave-safe mug. Enjoy free shipping within the continental U.S. |
Earn MOC Points for Medical Knowledge
ACP offers its members many ways to earn ABIM MOC points for Medical Knowledge and to make the process easier. See our MOC Timeline Page for details.